Evidence guide · US

Creatine monohydrate: what the trials show on muscle, memory and safety

Creatine monohydrate with resistance training added 1.37 kg more lean mass in older adults across 22 trials. A 2026 trial in 64 adults aged 45 to 65 reported gains without an exercise program at 10 g a day, after participants chose that route and were then randomized. What the evidence says on strength, memory, kidneys and women, doses used and local rules.

Review type: research summary. This page summarises published research and product labels, cited below.

Creatine is a compound the body makes in the pancreas, kidneys and liver from the amino acids arginine, glycine and methionine, and also takes in from meat and fish. About 95% of the body's creatine is stored in skeletal muscle, where much of it is held as phosphocreatine, a store of the phosphate used to regenerate ATP, the fuel for short, high-intensity effort. Creatine monohydrate is the form sold most widely as a supplement.

Short answer: creatine monohydrate is one of the most researched supplements, and the strongest results are for strength and lean mass when it is taken with resistance training. A meta-analysis of 22 randomized trials in older adults found 1.37 kg more lean tissue with creatine than placebo. A 2026 trial in 64 adults aged 45 to 65 reported gains in lean mass and strength even without an exercise program, but those adults chose an exercise or non-exercise route and were then randomized to creatine or placebo, and the creatine dose was 10 g a day, above the usual 3 to 5 g. Evidence for memory is moderate in quality and for other brain outcomes is low. Reviews of kidney and female safety found no serious harm signal, with a small rise in a blood marker, creatinine, that clinicians should know about.

Strength and lean mass in older adults

The most relevant pooled analysis for adults over 50 is a 2017 meta-analysis of randomized trials in which older adults trained with weights two to three days a week for 7 to 52 weeks and took either creatine or placebo. It included 22 studies and 721 participants with mean ages between 57 and 70. Creatine produced a larger gain in lean tissue mass (mean difference 1.37 kg, 95% confidence interval 0.97 to 1.76), in chest press strength (standardized mean difference 0.35, 0.16 to 0.53) and in leg press strength (0.24, 0.05 to 0.43). The authors report no conflicts of interest. The effect on leg strength is small, and the review covers people who trained, so it does not show what creatine does on its own.

The 2026 trial in middle-aged adults

A trial published in 2026 in the Journal of the International Society of Sports Nutrition looked at that question. Seventy-three healthy, sedentary adults first chose whether to join a non-exercise program or an exercise and diet program. Within each choice they were randomized, double-blind, to 5 g of creatine twice a day or a maltodextrin placebo for 12 weeks. Sixty-four people aged 45 to 65 (40 women and 24 men, average age 54.5) completed it. Body composition was measured by DXA scan, and blood samples and cognitive tests were taken at 0, 6 and 12 weeks.

  • Without exercise or diet changes: the authors report that creatine increased lean tissue mass, strength and muscular endurance, with favorable changes in selected blood lipids and HbA1c that the authors say should be read as exploratory.
  • With exercise and a weight-loss diet: creatine increased lean tissue mass, produced a greater fall in body fat percentage and improved strength and endurance.
  • Brain markers: the authors report improvements in selected markers of cognitive function and memory in both groups, and state that the individual cognitive and blood biomarker findings should be interpreted as exploratory.
  • Tolerability: the authors describe supplementation as well tolerated.

Three cautions apply. Participants chose the exercise or non-exercise route, so the comparison between those two routes is not randomized. The dose was 10 g a day, above the 3 to 5 g a day the International Society of Sports Nutrition describes as a recommended dose. One author discloses chairing the scientific advisory board of AlzChem, a company that makes creatine monohydrate, and having conducted industry-sponsored creatine research. One trial of 64 completers is a signal worth repeating, not a settled result.

Memory and thinking

A 2024 systematic review in Frontiers in Nutrition pooled 16 randomized trials with 492 participants aged 20.8 to 76.4, all using creatine monohydrate. Creatine improved memory (standardized mean difference 0.31, 95% confidence interval 0.18 to 0.44), attention time and processing speed time, but did not significantly improve overall cognitive function or executive function. The authors rate the certainty of the memory result as moderate and the certainty of processing speed, overall cognition, executive function and attention as low. Subgroup analyses suggested larger effects in people with diseases, in those aged 18 to 60 and in women. With 16 small trials, that last point is a pattern to test, not a finding to rely on.

Safety: kidneys and women

Concern about the kidneys comes largely from the fact that creatine intake raises serum creatinine, the blood marker doctors use to estimate kidney function. A 2025 systematic review and meta-analysis in BMC Nephrology included 21 studies, 12 of them in the creatinine meta-analysis (177 people on creatine and 263 controls). Those 12 studies showed a small, statistically significant rise in serum creatinine, which the authors conclude is likely to reflect metabolic turnover rather than kidney impairment. GFR did not change significantly in a separate analysis of 5 studies (69 people on creatine and 74 controls). Anyone who has blood tests for kidney function while taking creatine should tell the clinician, because creatinine alone can be misleading.

A 2020 systematic review in Nutrients looked at adverse outcomes in females. Twenty-nine studies with 951 participants monitored adverse events. It found no deaths or serious adverse events, and no significant differences in total adverse events (risk ratio 1.24, 95% confidence interval 0.51 to 2.98), gastrointestinal events (1.09, 0.53 to 2.24) or weight gain, or in measures of kidney or liver function. The authors note that only 9% of the 656 creatine studies they identified were in females only and call for better reporting of adverse events in future trials.

The International Society of Sports Nutrition's 2017 position stand concludes that short and long-term supplementation, up to 30 g a day for five years, is safe and well tolerated in healthy individuals and in a number of patient populations from infants to the elderly. Its 2021 follow-up paper says creatine is relatively well tolerated at the recommended 3 to 5 g a day, or 0.1 g per kilogram of body mass a day. The 2017 position stand was prepared at the request of the Council for Responsible Nutrition, and its lead author discloses industry-funded creatine research. Several authors of the 2021 paper disclose ties to creatine makers, including AlzChem. Those safety summaries come from researchers who have worked closely with the industry. The trial-level reviews above are the better check.

Our view

  • For adults who want more strength or lean mass, creatine monohydrate plus resistance training has the best evidence. Creatine without training has one 2026 trial behind it, not a proven alternative to exercise.
  • The International Society of Sports Nutrition describes 3 to 5 g a day as a recommended dose. A 2024 AESAN report treats 3.41 g of creatine monohydrate a day, providing 3 g of creatine, as an acceptable maximum for healthy adults. The 2026 trial used 10 g a day, so do not assume its results apply at those lower doses.
  • Creatine monohydrate was the form used in all 16 trials in the cognition review. Those trials say nothing about other forms of creatine, so a newer or more expensive form has no trial evidence behind it in this review.
  • Mention creatine to the clinician before kidney function tests, and speak to a doctor first if you have kidney disease, are pregnant or breastfeeding, or are giving it to a teenager.
  • Choose a product that lists the creatine dose per serving and publishes batch testing. Sale or registration as a supplement is not proof of the muscle, memory or safety results above.

US rules

In the US, creatine is sold as a dietary supplement. FDA is not authorized to approve dietary supplements for safety and effectiveness before they are marketed, and advises consumers to talk with a doctor, pharmacist or other healthcare professional before deciding to use one.

California's Assembly Bill 2030, Chapter 720 of the Statutes of 2026, begins on January 1, 2027. After that date, dietary supplements labeled, marketed or otherwise represented for weight loss or muscle building may not be sold to a person in California under 18 without a prescription. Creatine is one factor a court may consider when deciding whether a product is represented that way, and the ingredient alone does not automatically bring every creatine product within the law. Enforcement is by the Attorney General, county counsel or city attorneys, with civil penalties of up to $500 per violation. Private individuals have no cause of action under that section. The statute says the penalties it sets are cumulative and do not diminish rights, remedies or penalties under other laws. Retailers and brands selling to California should read the full page on AB 2030.

FAQ

How much creatine should I take?

The International Society of Sports Nutrition describes 3 to 5 g a day, or 0.1 g per kilogram of body mass a day, as the recommended dosage. The authorized claim in Great Britain is tied to a daily intake of 3 g. The 2026 midlife trial used 5 g twice a day.

Is creatine bad for your kidneys?

A 2025 review included 21 studies. A meta-analysis of 12 of them (177 people on creatine and 263 controls) found a small rise in serum creatinine, and the authors conclude the rise likely reflects metabolic turnover rather than kidney impairment. GFR did not change significantly in a separate analysis of 5 studies. The review was open to any health status and includes people with type 2 diabetes, so it is not evidence limited to healthy people. Anyone with kidney disease should take advice from a doctor before using creatine.

Does creatine work for women?

Women were 40 of the 64 completers in the 2026 midlife trial, and a 2020 review of 29 monitored studies with 951 participants found no serious adverse events in females. The cited reviews do not give a separate efficacy figure for women, and women remain under-represented in the creatine literature, which the 2020 review's authors point out.

Does creatine help your brain?

There is moderate-certainty evidence for a small benefit to memory from a 2024 meta-analysis of 16 trials. Attention time and processing speed time improved, but that evidence is low certainty. Overall cognitive function and executive function did not improve significantly, and the evidence for those outcomes is also low certainty. It does not show that creatine prevents dementia.

Sources

These are the documents this page relies on.

  1. Effects of creatine supplementation with and without exercise and diet intervention on body composition, cognitive function, and markers of health in middle-aged and older adults. J Int Soc Sports Nutr. 2026 (ISRCTN83081058)Journal of the International Society of Sports Nutrition (PubMed 42578920)
  2. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access J Sports Med. 2017Open Access Journal of Sports Medicine (PubMed 29138605)
  3. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18Journal of the International Society of Sports Nutrition (PubMed 28615996)
  4. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021Journal of the International Society of Sports Nutrition (PubMed 33557850)
  5. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024Frontiers in Nutrition (PubMed 39070254)
  6. Effect of creatine supplementation on kidney function: a systematic review and meta-analysis. BMC Nephrol. 2025BMC Nephrology (PubMed 41199218)
  7. Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis. Nutrients. 2020Nutrients (PubMed 32549301)
  8. Report of the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) on the risk associated with the consumption of food supplements that contain creatine as an ingredientSpanish Agency for Food Safety and Nutrition (AESAN)
  9. Information for consumers on using dietary supplementsUS Food and Drug Administration
  10. AB 2030 (2025-2026): bill textCalifornia Legislative Information